Preclinical evaluation of 4‐[3,5‐bis(2‐chlorobenzylidene)‐4‐oxo‐piperidine‐1‐yl]‐4‐oxo‐2‐butenoic acid, in a mouse model of lung cancer xenograft

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12406PMID 24102070PMCID PMC3838689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EF24 suppresses maturation and inflammatory response in dendritic cells.

  2012cited by this paper
• Molecular link mechanisms between inflammation and cancer.

  2012cited by this paper
• Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers

  2012cited by this paper
• Cardamonin sensitizes tumour cells to TRAIL through ROS‐ and CHOP‐mediated up‐regulation of death receptors and down‐regulation of survival proteins

  2012cited by this paper
• NF‐κB and the link between inflammation and cancer

  2012cited by this paper
• The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress

  2012cited by this paper
• A Toll-Like Receptor-4-Interacting Surfactant Protein-A-Derived Peptide Suppresses Tumor Necrosis Factor-α Release from Mouse JAWS II Dendritic Cells

  2011cited by this paper
• NF-κB addiction and its role in cancer: ‘one size does not fit all’

  2011cited by this paper
• Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival

  2011influential reference
• Lung Cancer Chemoprevention with Celecoxib in Former Smokers

  2011cited by this paper
• NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.

  2011cited by this paper
• Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer

  2011cited by this paper
• The Rate of NF-κB Nuclear Translocation Is Regulated by PKA and A Kinase Interacting Protein 1

  2011cited by this paper
• Quantifying nuclear p65 as a parameter for NF‐κB activation: Correlation between ImageStream cytometry, microscopy, and Western blot

  2011cited by this paper
• Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

  2011cited by this paper
• Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.

  2011cited by this paper
• The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

  2011cited by this paper
• CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

  2010cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib

  2009cited by this paper
• Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma

  2009cited by this paper
• Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

  2009cited by this paper
• Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.

  2008cited by this paper
• Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IkappaBalpha.

  2008cited by this paper
• The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2

  2008cited by this paper
• Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin

  2008cited by this paper
• Bid: a Bax-like BH3 protein

  2008influential reference
• Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

  2008cited by this paper
• Host Nuclear Factor-κB Activation Potentiates Lung Cancer Metastasis

  2008cited by this paper
• Inflammatory tales of liver cancer.

  2007cited by this paper
• YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

  2007cited by this paper
• Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice

  2007cited by this paper
• Signalling networks regulating cyclooxygenase-2.

  2006cited by this paper
• Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

  2006cited by this paper
• Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions

  2006cited by this paper
• Transcription-based COX-2 inhibition: A therapeutic strategy

  2006cited by this paper
• Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

  2006cited by this paper
• Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes.

  2005cited by this paper
• Minireview: Cyclin D1: normal and abnormal functions.

  2004cited by this paper
• Cyclooxygenase as a Target in Lung Cancer

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• NF-κB functions as a tumour promoter in inflammation-associated cancer

  2004cited by this paper
• COX-2 inhibition and lung cancer.

  2004cited by this paper
• Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines

  2003cited by this paper
• NF-κB-dependent Induction of Cyclin D1 by Retinoblastoma Protein (pRB) Family Proteins and Tumor-derived pRB Mutants*

  2003cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002influential reference
• Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells.

  1999cited by this paper
• Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients.

  1998cited by this paper
• Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.

  1998cited by this paper
• Metalloproteinases in tumor progression: the contribution of MMP-9.

  1994influential reference
• Role of inducible cyclooxygenase (COX-2) in inflammation.

  1994cited by this paper
• A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.

  1994cited by this paper

• Recent advances in piperidones as privileged scaffolds for drug discovery and development

  2026cites this paper
• Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.

  2024cites this paper
• Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives

  2022cites this paper
• CLEFMA Induces the Apoptosis of Oral Squamous Carcinoma Cells through the Regulation of the P38/HO-1 Signalling Pathway

  2022cites this paper
• Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics

  2022cites this paper
• Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: an update with promising analogues.

  2021cites this paper
• Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms.

  2021cites this paper
• Differential oxidative and pro-apoptotic response of cancer and normal cells to an anti-inflammatory agent CLEFMA

  2021cites this paper
• Exploration of Noncovalent Interactions, Chemical Reactivity, and Nonlinear Optical Properties of Piperidone Derivatives: A Concise Theoretical Approach

  2020cites this paper
• CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells

  2019cites this paper
• Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.

  2019cites this paper
• N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.

  2018cites this paper
• Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.

  2018cites this paper
• Synthesis, crystal structures and anti-inflammatory activity of four 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivatives.

  2018cites this paper
• Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method

  2016cites this paper
• Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action.

  2015cites this paper
• Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer

  2015cites this paper
• A Bayesian Integrative Model for Genetical Genomics with Spatially Informed Variable Selection

  2014cites this paper
• Oridonin inhibits mTOR signaling and the growth of lung cancer tumors

  2014cites this paper